Key result
Mitral annuloplasty with CABG shows no survival benefit over OPCAB but is linked to less MR.
Why the study?
Does mitral annuloplasty with revascularization improve outcomes compared to isolated OPCAB in patients with moderate ischemic mitral regurgitation?
Cohort (n=140)
No
Does mitral annuloplasty with revascularization improve outcomes compared to isolated OPCAB in patients with moderate ischemic mitral regurgitation?
Answers are grounded in this paper and cite their sources.
Concomitant mitral annuloplasty with revascularization is more effective than OPCAB alone in preventing recurrent MR in patients with moderate ischemic MR and LVEF ≤40%.
PURPOSE: To compare the outcomes of isolated off-pump coronary artery bypass grafting (OPCAB) to those of mitral annuloplasty (MAP) with revascularization in patients with moderate ischemic mitral regurgitation (MR). METHODS: Between April 2001 and December 2009, 140 patients with moderate ischemic MR who underwent isolated OPCAB (OPCAB group, n = 77) or MAP with revascularization (MAP group, n = 63) were analyzed. RESULTS: Freedom from cardiac-related death at eight years was similar between groups (78.4 ± 5.5%, the OPCAB group versus 81.5 ± 5.9%, the MAP group, p = 0.297). In patients with left ventricular ejection fraction (LVEF) >40%, the MAP group were similar to the OPCAB group in freedom from recurrent MR at eight years (85.7± 10.0% versus 84.9 ± 8.3%, p = 0.738), but a significant difference was found in patients with LVEF ≤40% (93.5± 4.5%, the MAP group versus 36.9 ± 18.4%, the OPCAB group, p = 0.013). On multivariate analysis, emergency operation and low LVEF were predictive of recurrent MR. CONCLUSION: Concomitant MAP was more effective against recurrent MR than was OPCAB alone, in patients with LVEF ≤40%. We suggest that MAP should be considered in moderate ischemic MR with low LVEF.
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2012) conducted a cohort in Moderate ischemic mitral regurgitation (n=140). Mitral annuloplasty (MAP) with revascularization vs. Isolated off-pump coronary artery bypass grafting (OPCAB) was evaluated on Freedom from cardiac-related death at eight years (p=0.297). Mitral annuloplasty with CABG had similar 8-year freedom from cardiac death as isolated OPCAB (81.5% vs 78.4%), but reduced recurrent mitral regurgitation in patients with LVEF ≤40%.
Synapse has enriched 10 related papers. Consider them for comparative context: